Amanote Research

Amanote Research

    RegisterSign In

Evaluation of Parkinson Disease Risk Variants as Expression-QTLs

PLoS ONE - United States
doi 10.1371/journal.pone.0046199
Full Text
Open PDF
Abstract

Available in full text

Categories
Multidisciplinary
Date

October 5, 2012

Authors
Jeanne C. LatourelleAlexandra DumitriuTiffany C. HadziThomas G. BeachRichard H. Myers
Publisher

Public Library of Science (PLoS)


Related search

Overlap Between Parkinson Disease and Alzheimer Disease inABCA7functional Variants

Neurology: Genetics
NeurologyGenetics
2016English

Pathophysiologic Effects of CHCHD2 Variants Associated With Late-Onset Parkinson Disease

Human Mutation
Genetics
2017English

Evaluation of European Coeliac Disease Risk Variants in a North Indian Population

European Journal of Human Genetics
Genetics
2014English

Hypertension, Hypercholesterolemia, Diabetes, and Risk of Parkinson Disease

Neurology
Neurology
2007English

18f-Fluorodeoxyglucose PET in the Evaluation of Parkinson Disease

PET Clinics
MedicineNuclear MedicineRadiologyRadiationImaging
2010English

Whole Exome Sequencing of Rare Variants in EIF4G1 and VPS35 in Parkinson Disease

Neurology
Neurology
2013English

Serum Vitamin D and the Risk of Parkinson Disease

Archives of Neurology
2010English

Visual Tests Predict Dementia Risk in Parkinson Disease

Neurology: Clinical Practice
Neurology
2019English

Association of Parkinson Disease With Structural and Regulatory Variants in the HLA Region

American Journal of Human Genetics
Genetics
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy